title: Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?
authors.forename: I
authors.initials: I
authors.lastname: Mezzaroma
authors.forename: A
authors.initials: A
authors.lastname: Giovannetti
authors.forename: E
authors.initials: E
authors.lastname: Pinter
authors.forename: F
authors.initials: F
authors.lastname: Ensoli
authors.forename: F
authors.initials: F
authors.lastname: Aiuti
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000517:prevention & control; D000328:Adult; D019380:Anti-HIV Agents / Q000276:immunology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000517:prevention & control
chemical_list: D019380:Anti-HIV Agents